References
- Huerta S , MurrayB, OlsonC, PatelP, AnthonyT. Current evidence-based opinions in the management of adenocarcionoma of the rectum. Indian J. Surg.71(6), 356–362 (2009).
- Huerta S . Rectal cancer and importance of chemoradiation in the treatment. Adv. Exp. Med. Biol.685, 124–133 (2010).
- Huerta S . Critical concepts in the oncogenesis of adenocarcionoma of the rectum. Crit. Rev. Oncog.17(4), 323–329 (2012).
- Huerta S , HromJ, GaoXet al. Tissue microarray constructs to predict a response to chemoradiation in rectal cancer. Dig. Liver Dis.42(10), 679–684 (2010).
- Wang Y , CummingsB, CattonPet al. Primary radical external beam radiotherapy of rectal adenocarcinoma: long term outcome of 271 patients. Radiother. Oncol.77(2), 126–132 (2005).
- Habr-Gama A , PerezRO, NadalinWet al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann. Surg.240(4), 711–717 (2004).
- Huerta S . Interval between neoadjuvant chemoradiation and surgery for the management of rectal cancer. J. Gastrointest. Surg.15(7), 1292 (2011).
- Maas M , Beets-TanRG, LambregtsDMet al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J. Clin. Oncol.29(35), 4633–4640 (2011).
- Tepper JE , O’NeilBH. Minimizing therapy and maximizing outcomes in rectal cancer. J. Clin. Oncol.29(35), 4604–4606 (2011).
- Smith JD , RubyJA, GoodmanKAet al. Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy. Ann. Surg.256(6), 965–972 (2012).
- Dalton RS , VelineniR, OsborneMEet al. A single-centre experience of chemoradiotherapy for rectal cancer: is there potential for nonoperative management? Colorectal Dis.14(5), 567–571 (2012).
- Glynne-Jones R , WallaceM, LivingstoneJI, Meyrick-ThomasJ. Complete clinical response after preoperative chemoradiation in rectal cancer: is a ‘wait and see’ policy justified?Dis. Colon Rectum51(1), 10–19 (2008).
- Bonnen M , CraneC, VautheyJNet al. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int. J. Radiat. Oncol. Biol. Phys.60(4), 1098–1105 (2004).
- Hughes R , Glynne-JonesR, GraingerJet al. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision? Int. J. Colorectal Dis. 21(1), 11–17 (2006).
- Mohiuddin M , MarksG, BannonJ. High-dose preoperative radiation and full thickness local excision: a new option for selected T3 distal rectal cancers. Int. J. Radiat. Oncol. Biol. Phys.30(4), 845–849 (1994).
- Onaitis MW , NooneRB, FieldsRet al. Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival. Ann. Surg. Oncol.8(10), 801–806 (2001).
- Schell SR , ZloteckiRA, MendenhallWM, MarshRW, VautheyJN, CopelandEM3rd. Transanal excision of locally advanced rectal cancers downstaged using neoadjuvant chemoradiotherapy. J. Am. Coll. Surg.194(5), 584–590 (2002).
- Neuman HB , ElkinEB, GuillemJGet al. Treatment for patients with rectal cancer and a clinical complete response to neoadjuvant therapy: a decision analysis. Dis. Colon Rectum52(5), 863–871 (2009).